Stock split history for Bio-Techne. Bio-Techne Corp market cap as of August 30, is $B. Compare TECH With Other Stocks. Bio-Techne beats third-quarter estimates on improving demand for biotech products. Bio-Techne on Wednesday beat third-quarter profit and revenue estimates. Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It. Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic.
Bio-Techne Corp stock (TECH) in USD · Bio-Techne Corp stock performance at a glance · About Bio-Techne Corp · Turning your stock options or RSUs into cold, hard. Stock Information. Bio-Techne Corporation. Nasdaq: TECH. Aug 30, • PM EDT | View Detailed Stock Info. Price $ Change (%). Volume. Bio-Techne Corp TECH:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date05/15/24 · 52 Week Low · Analyze your stocks, your way. Leverage the Nasdaq+ Scorecard to analyze stocks based on your investment priorities and our market data. Subscribe Now ->. TECH Bio-Techne · High. · Low. · Volume. K · Open. · Pre Close. · Turnover. M · Turnover Ratio. % · P/E (Static). See the latest Bio-Techne Corp stock price (TECH:XNAS), related news, valuation, dividends and more to help you make your investing decisions. On Thursday morning 08/29/ the Bio-Techne Corp share started trading at the price of $ Compared to the closing price on Wednesday 08/28/ on BTT. Bio-Techne Corporation's latest quarterly earnings per share is $ with a past EPS surprise of $ The latest EPS estimate is $ Read more about Bio-. Bio Techne | TECHStock Price | Live Quote | Historical Chart ; Illumina, , , % ; IQVIA Holdings, , , %. Bio-Techne Corp. ; Market Value, $B ; Shares Outstanding, M ; EPS (TTM), $ ; P/E Ratio (TTM), ; Dividend Yield, %. The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.
PKBO $ Peak Bio Inc. ; ATPC $ Agape ATP Corporation ; EFTR $ eFFECTOR Therapeutics Inc. ; TOVX $ Theriva Biologics, Inc. ; CNTB $ Connect. Bio-Techne stock price target cut to $ from $ at Stifel Nicolaus. Nov. 2, at a.m. ET by Tomi Kilgore. Bio-Techne Corp. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Is Bio-Techne Corp stock A Buy? Bio-Techne Corp holds several negative signals and we believe that it will still perform weakly in the next couple of days or. In the current month, TECH has received 8 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. TECH average Analyst price target in the past 3 months is $ Stock analysis for Bio-Techne Corp (TECH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Discover historical prices for TECH stock on Yahoo Finance. View daily, weekly or monthly format back to when Bio-Techne Corporation stock was issued. In the current month, TECH has received 8 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. TECH average Analyst price target in the past 3 months is $ Bio-Techne (TECH) has a Smart Score of 8 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund.
Investing · Tech · Politics · Video · Watchlist · Investing Club. Join IC. PRO Profile. MORE. BioNTech SE is a Germany-based clinical-stage biotechnology. Discover real-time Bio-Techne Corp Common Stock (TECH) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Bio-Techne Corp (TECH) ; Open: ; Day's Range: ; 52 wk Range: ; Volume: , ; Average Vol. (3m): , Biotech Stock Weekly Watch List · KalVista Pharmaceuticals Inc. (NASDAQ: KALV) is a biopharmaceutical company with a market cap of. Overall, BIO-TECHNE Corp stock has a Value Grade of F, Quality Grade of A, Momentum Grade of D. Whether or not you should buy BIO-TECHNE Corp stock will.
Revealed: Ian King's \
View the latest Bio-Techne Corp. (TECH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get the latest news on biotech funding, stocks, mergers and acquisitions, IPOs, bankruptcies, and more from BioSpace.
Product And Inventory Management | Government Pension Plans In India